In animal models, the combination of ZD55-SATB1 and DTX significantly reduced tumor growth, increased pro-apoptotic factors such as caspase-3 and caspase-8, and decreased levels of anti-apoptotic proteins such as Bcl-2, along with reductions in angiogenic markers (CD31) (183). Here, SATB1 is linked to neoplasm.